Financials Centenial Surgical Suture Ltd.
Equities
CSURGSU6
INE405H01018
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
115.4 INR | -9.13% | +0.66% | +14.29% |
Mar. 29 | Centenial Surgical Suture Ltd. Announces Board Changes | CI |
Feb. 14 | Centenial Surgical Suture Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 299.2 | 180.2 | 127 | 156 | 221.6 | 225 |
Enterprise Value (EV) 1 | 432.1 | 307.9 | 318.9 | 347.6 | 368.8 | 371.5 |
P/E ratio | 19.4 x | 8.94 x | 9.8 x | 16.2 x | 35.3 x | 25.4 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.57 x | 0.32 x | 0.23 x | 0.42 x | 0.5 x | 0.43 x |
EV / Revenue | 0.82 x | 0.55 x | 0.57 x | 0.94 x | 0.83 x | 0.71 x |
EV / EBITDA | 9.97 x | 5.98 x | 6.32 x | 8.22 x | 9.96 x | 10.4 x |
EV / FCF | 22.3 x | 19.8 x | 16.6 x | -39.8 x | 6.84 x | 52.9 x |
FCF Yield | 4.48% | 5.06% | 6.02% | -2.51% | 14.6% | 1.89% |
Price to Book | 1.15 x | 0.64 x | 0.44 x | 0.53 x | 0.73 x | 0.72 x |
Nbr of stocks (in thousands) | 3,648 | 3,648 | 3,648 | 3,648 | 3,648 | 3,648 |
Reference price 2 | 82.00 | 49.40 | 34.80 | 42.75 | 60.75 | 61.67 |
Announcement Date | 8/9/18 | 9/5/19 | 9/2/20 | 9/1/21 | 7/14/22 | 8/28/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 527.5 | 560.5 | 556.1 | 369.3 | 444.3 | 526.6 |
EBITDA 1 | 43.33 | 51.45 | 50.47 | 42.29 | 37.02 | 35.79 |
EBIT 1 | 37.86 | 44.6 | 43.12 | 34.54 | 29.22 | 29.98 |
Operating Margin | 7.18% | 7.96% | 7.75% | 9.35% | 6.58% | 5.69% |
Earnings before Tax (EBT) 1 | 24.13 | 28.42 | 21.55 | 15.3 | 10.74 | 14.63 |
Net income 1 | 15.42 | 20.16 | 12.96 | 9.618 | 6.271 | 8.859 |
Net margin | 2.92% | 3.6% | 2.33% | 2.6% | 1.41% | 1.68% |
EPS 2 | 4.227 | 5.527 | 3.550 | 2.636 | 1.719 | 2.428 |
Free Cash Flow 1 | 19.36 | 15.59 | 19.2 | -8.725 | 53.91 | 7.029 |
FCF margin | 3.67% | 2.78% | 3.45% | -2.36% | 12.14% | 1.33% |
FCF Conversion (EBITDA) | 44.69% | 30.3% | 38.04% | - | 145.65% | 19.64% |
FCF Conversion (Net income) | 125.57% | 77.31% | 148.13% | - | 859.73% | 79.34% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 8/9/18 | 9/5/19 | 9/2/20 | 9/1/21 | 7/14/22 | 8/28/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 133 | 128 | 192 | 192 | 147 | 147 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 3.068 x | 2.482 x | 3.803 x | 4.532 x | 3.977 x | 4.095 x |
Free Cash Flow 1 | 19.4 | 15.6 | 19.2 | -8.73 | 53.9 | 7.03 |
ROE (net income / shareholders' equity) | 6.1% | 7.45% | 4.57% | 3.31% | 2.1% | 2.89% |
ROA (Net income/ Total Assets) | 4.26% | 4.97% | 4.29% | 3.1% | 2.78% | 2.93% |
Assets 1 | 362.3 | 405.4 | 301.9 | 310.4 | 225.6 | 302 |
Book Value Per Share 2 | 71.40 | 76.90 | 78.40 | 81.10 | 82.80 | 85.20 |
Cash Flow per Share 2 | 2.940 | 0.8900 | 1.980 | 1.480 | 0.7000 | 0.9000 |
Capex 1 | 7.13 | 9.82 | 10.8 | 8.38 | 1.57 | 1.61 |
Capex / Sales | 1.35% | 1.75% | 1.94% | 2.27% | 0.35% | 0.31% |
Announcement Date | 8/9/18 | 9/5/19 | 9/2/20 | 9/1/21 | 7/14/22 | 8/28/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+14.29% | 5.55M | |
-5.51% | 182B | |
+2.33% | 111B | |
-3.62% | 68.48B | |
+1.52% | 49.69B | |
+8.06% | 44.46B | |
+6.38% | 40.67B | |
+23.35% | 31.22B | |
+0.67% | 26.09B | |
+18.48% | 25.32B |
- Stock Market
- Equities
- CSURGSU6 Stock
- Financials Centenial Surgical Suture Ltd.